cysteine has been researched along with Hyperchylomicronemia Late Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruckert, E; Chapman, MJ; Foglietti, MJ; Giral, P; Jacob, N; Turpin, G | 1 |
| Brennan, SO; George, PM; Janus, ED; Nye, ER; Rall, SC; Wardell, MR; Weisgraber, KH | 1 |
1 trial(s) available for cysteine and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia.
Topics: Atorvastatin; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Female; Fenofibrate; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Triglycerides | 2001 |
1 other study(ies) available for cysteine and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Apolipoprotein E2-Dunedin (228 Arg replaced by Cys): an apolipoprotein E2 variant with normal receptor-binding activity.
Topics: Amino Acid Sequence; Apolipoprotein E2; Apolipoproteins E; Arginine; Cysteine; Diseases in Twins; Electrophoresis, Gel, Two-Dimensional; Genetic Variation; Heterozygote; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type V; Lipoproteins; Male; Middle Aged; Peptide Mapping; Protein Conformation; Receptors, LDL | 1990 |